Changes in the Gut Microbiota are Associated with Hypertension, Hyperlipidemia, and Type 2 Diabetes Mellitus in Japanese Subjects

• Published in: Nutrients Vol. 12; no. 10; p. 2996
• Main Authors: Takagi, Tomohisa, Naito, Yuji, Kashiwagi, Saori, Uchiyama, Kazuhiko, Mizushima, Katsura, Kamada, Kazuhiro, Ishikawa, Takeshi, Inoue, Ryo, Okuda, Kayo, Tsujimoto, Yoshimasa, Ohnogi, Hiromu, Itoh, Yoshito
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 30.09.2020; MDPI
• Subjects: Actinobacteria - isolation & purification; Adolescent; Adult; Aged; Bacteria; Bacteroidetes; Bacteroidetes - isolation & purification; Bifidobacterium; Bifidobacterium - isolation & purification; Blood pressure; Case-Control Studies; Collinsella; Comorbidity; Diabetes; Diabetes Mellitus, Type 2 - microbiology; Disease; DNA; DNA, Bacterial - isolation & purification; enzymes; Feces; Feces - microbiology; Female; Gastrointestinal Microbiome; Genetic testing; Genomes; Gut microbiota; Health care; Humans; hyperlipidemia; Hyperlipidemias - microbiology; Hypertension; Hypertension - microbiology; intestinal microorganisms; Irritable bowel syndrome; Japan; Male; Microbiota; Middle Aged; nutrients; patients; Taxonomy; Young Adult; Japan; United States > US; Germany; type 2 diabetes mellitus; hyperlipidemia; hypertension; gut microbiota
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu12102996

The human gut microbiota is involved in host health and disease development. Therefore, lifestyle-related diseases such as hypertension (HT), hyperlipidemia (HL), and type 2 diabetes mellitus (T2D) may alter the composition of gut microbiota. Here, we investigated gut microbiota changes related to these diseases and their coexistence. This study involved 239 Japanese subjects, including healthy controls (HC). The fecal microbiota was analyzed through the isolation of bacterial genomic DNA obtained from fecal samples. Although there were no significant differences in the microbial structure between groups, there was a significant difference in the α-diversity between HC and the patients in whom two diseases coexisted. Moreover, Actinobacteria levels were significantly increased, whereas Bacteroidetes levels were significantly decreased in all disease groups. At the genus level, Bifidobacterium levels were significantly increased in the HL and T2D groups, as were those of Collinsella in all disease groups. In contrast, Alistipes levels were significantly lower in the HL group. Furthermore, metabolic enzyme families were significantly increased in all disease groups. Interestingly, the structure and function of the gut microbiota showed similar profiles in all the studied diseases. In conclusion, several changes in the structure of the gut microbiota are associated with T2D, HT, and HL in Japanese subjects.